In contrast, the neuromodulator adenosine reduces acute neuroinflammatory injury following ICH by inhibiting the production of proinflammatory cytokines by activating cell surface-specific receptors, decreasing the production of tumor necrosis factor mRNA in the body, and reducing hematoma size and neutrophil infiltration after brain hemorrhage (41). The gene discussed is TNF; the disease is hematoma.